Top Markets
Coin of the day
Pharmanutra S.p.A. Pharmanutra S.p.A.

Pharmanutra S.p.A.

PHN
株式のランク #9895
Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise,... Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.
株価
$97.03
最終同期: 2026-08-28
時価総額
$929.06M
変化(1日)
-0.12%
変化(1年)
70.33%
IT
取引 Pharmanutra S.p.A. (PHN)

カテゴリー

Pharmanutra S.p.A.(PHN)の利益
2026 時点の利益 TTM: 0
Pharmanutra S.p.A. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Pharmanutra S.p.A. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。